Proteomics analysis of enzalutamide-treated castration-sensitive and castration-resistant prostate cancer cell lines

被引：0
|
作者：
Liburd, Lincoln E., II
Paromov, Victor
Pratap, Siddharth
Stewart, LaMonica
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-C052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C052
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The role of enzalutamide in the treatment of castration-resistant prostate cancer
    Rawlinson, Alex
    Mohammed, Aza
    Miller, Marek
    Kunkler, Roger
    FUTURE ONCOLOGY, 2012, 8 (09) : 1073 - 1081
  • [22] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [23] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [24] Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis
    Santoni, Matteo
    Massari, Francesco
    Rizzo, Alessandro
    Mollica, Veronica
    Cimadamore, Alessia
    Montironi, Rodolfo
    Battelli, Nicola
    TUMORI JOURNAL, 2023, 109 (02): : 157 - 163
  • [25] Myocardial bridge in a patient with castration-resistant metastatic prostate cancer treated with enzalutamide
    Giordano, Giulia
    Mastrantoni, Luca
    Colloca, Giuseppe Ferdinando
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1754 - 1756
  • [26] Biomarker Analysis of Men With Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Treated With Pembrolizumab
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 15 - 16
  • [27] Retrospective analysis of fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide.
    Sridhar, Srikala S.
    Smith, Alan D.
    Fallah-Rad, Nazanin
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] CAN LOCAL RADIOTHERAPY CONVERT METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TO A CASTRATION-SENSITIVE DISEASE? A CASE REPORT
    Terrevazzi, Sara
    Niespolo, Rita Marina
    Colciago, Riccardo Ray
    Villa, Stefano Lorenzo
    Pacifico, Pietro
    Arcangeli, Stefano
    ANTICANCER RESEARCH, 2020, 40 (08) : 4592 - 4592
  • [29] Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review
    F. Kunath
    P. J. Goebell
    B. Wullich
    D. Sikic
    A. Kahlmeyer
    World Journal of Urology, 2020, 38 : 601 - 611
  • [30] Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review
    Kunath, F.
    Goebell, P. J.
    Wullich, B.
    Sikic, D.
    Kahlmeyer, A.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 601 - 611
12345